{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:03:52Z","timestamp":1768986232983,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T00:00:00Z","timestamp":1439337600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10689-015-9827-7","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T04:56:18Z","timestamp":1439268978000},"page":"539-544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy"],"prefix":"10.1007","volume":"14","author":[{"given":"Jessica E.","family":"van der Aa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob P.","family":"Hoogendam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els S. F.","family":"Butter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet G. E. M.","family":"Ausems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 H. M.","family":"Verheijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P.","family":"Zweemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,12]]},"reference":[{"issue":"5","key":"9827_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9827_CR2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","volume":"51","author":"RM Brohet","year":"2014","unstructured":"Brohet RM, Velthuizen ME, Hogervorst FBL, Meijers-Heijboer HEJ et al (2014) Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet 51:98\u2013107","journal-title":"J Med Genet"},{"issue":"4","key":"9827_CR3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/1055-9965.EPI-11-0888","volume":"21","author":"FJ Couch","year":"2012","unstructured":"Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ et al (2012) Consortium of Investigators of Modifiers of BRCA1\/2. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomark Prev 21(4):645\u2013657","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5645","key":"9827_CR4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH (2003) Mandell JB; New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646","journal-title":"Science"},{"issue":"3","key":"9827_CR5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","volume":"124","author":"DM Kolk van der","year":"2010","unstructured":"van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJ, de Vries J, van der Hout AH, Oosterwijk JC (2010) Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 124(3):643\u2013651","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"9827_CR6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","volume":"296","author":"A Finch","year":"2006","unstructured":"Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P (2006) Narod SA; Hereditary Ovarian Cancer Clinical Study Group. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA 296(2):185\u2013192","journal-title":"JAMA"},{"issue":"21","key":"9827_CR7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609\u20131615","journal-title":"N Engl J Med"},{"issue":"8","key":"9827_CR8","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","volume":"26","author":"ND Kauff","year":"2008","unstructured":"Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, Barakat RR, Hudis C, Norton L, Offit K, Rebbeck TR (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331\u20131337","journal-title":"J Clin Oncol"},{"issue":"21","key":"9827_CR9","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA (2002) Van\u2019t Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL; Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616\u20131622","journal-title":"N Engl J Med"},{"key":"9827_CR10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12905-014-0150-5","volume":"14","author":"C Marchetti","year":"2014","unstructured":"Marchetti C, De Felice F, Palaia I, Perniola G, Musella A, Musio D, Muzii L, Tombolini V, Panici PB (2014) Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Women\u2019s Health 14:150","journal-title":"BMC Women\u2019s Health"},{"issue":"2","key":"9827_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9827_CR12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djv033","volume":"107","author":"BA Heemskerk-Gerritsen","year":"2015","unstructured":"Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, Ausems MG, Coll\u00e9e JM, van Doorn HC, GomezGarcia EB, Kets CM, van Leeuwen FE, Meijers-Heijboer HE, Mourits MJ, van Os TA, Vasen HF, Verhoef S, Rookus MA, Hooning MJ (2015) Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst 107(5):812\u2013822","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"9827_CR13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1525-1438.2006.00480.x","volume":"16","author":"KN Gaarenstroom","year":"2006","unstructured":"Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ et al (2006) Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int J Gynecol Cancer 16(Suppl 1):54\u201359","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"9827_CR14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","volume":"96","author":"BB Hermsen","year":"2007","unstructured":"Hermsen BB, Olivier RI, Verheijen RH, van Beurden M, de Hullu JA, Massuger LF, Burger CW, Brekelmans CT, Mourits MJ, de Bock GH, Gaarenstroom KN, van Boven HH, Mooij TM, Rookus MA (2007) No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study. Br J Cancer 96(9):1335\u20131342","journal-title":"Br J Cancer"},{"key":"9827_CR15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2005.01.024","volume":"97","author":"PA Meeuwissen","year":"2005","unstructured":"Meeuwissen PA, Seynaeve C, Brekelmans CT, Meijers-Heijboer HJ, Klijn JG, Burger CW (2005) Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer. Gynecol Oncol 97:476\u2013482","journal-title":"Gynecol Oncol"},{"issue":"6","key":"9827_CR16","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.bjc.6603015","volume":"94","author":"AL Oei","year":"2006","unstructured":"Oei AL, Massuger LF, Bulten J, Ligtenberg MJ, Hoogerbrugge N, de Hullu JA (2006) Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer 94(6):814\u2013819","journal-title":"Br J Cancer"},{"issue":"1","key":"9827_CR17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2005.08.038","volume":"100","author":"RI Olivier","year":"2006","unstructured":"Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M (2006) CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol 100(1):20\u201326","journal-title":"Gynecol Oncol"},{"key":"9827_CR18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ejca.2004.10.029","volume":"41","author":"HF Vasen","year":"2005","unstructured":"Vasen HF, Tesfay E, Boonstra H, Mourits MJ, Rutgers E, Verheijen R et al (2005) Early detection of breast and ovarian cancer in families with BRCA mutations. Eur J Cancer 41:549\u2013554","journal-title":"Eur J Cancer"},{"issue":"4","key":"9827_CR19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ijc.24038","volume":"124","author":"NM Velde van der","year":"2009","unstructured":"van der Velde NM, Mourits MJ, Arts HJ, de Vries J, Leegte BK, Dijkhuis G, Oosterwijk JC, de Bock GH (2009) Time to stop ovarian cancer screening in BRCA1\/2 mutation carriers. Int J Cancer 124(4):919\u2013923","journal-title":"Int J Cancer"},{"key":"9827_CR20","first-page":"A2392","volume":"154","author":"JA Hullu de","year":"2010","unstructured":"de Hullu JA, Kets CM, Massuger LF, Ligtenberg ML, van Ham MA, Hoogerbrugge N (2010) Familiaire belasting voor ovariumcarcinoom: beleid. Ned Tijdschr Geneeskd 154:A2392","journal-title":"Ned Tijdschr Geneeskd"},{"key":"9827_CR21","unstructured":"Vasen HFA, Hes FJ (2010) Richtlijnen voor diagnostiek en preventie. STOET & WKO, Leiden (4e druk)"},{"issue":"1","key":"9827_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/gtmb.2008.0067","volume":"13","author":"MS Beattie","year":"2009","unstructured":"Beattie MS, Crawford B, Lin F, Vittinghoff E, Ziegler J (2009) Uptake, time course and predictors of risk-reducing surgeries in BRCA carriers. Genet Test Mol Biomark 13(1):51\u201356","journal-title":"Genet Test Mol Biomark"},{"issue":"3","key":"9827_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/GIM.0b013e318163487d","volume":"10","author":"AR Bradbury","year":"2008","unstructured":"Bradbury AR, Ibe CN, Dignam JJ, Cummings SA, Verp M, White MA, Artioli G, Dudlicek L, Olopade OI (2008) Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet Med 10(3):161\u2013166","journal-title":"Genet Med"},{"key":"9827_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-014-3134-0","volume":"148","author":"X Chai","year":"2014","unstructured":"Chai X, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs JE et al (2014) Use of risk-reducing surgeries in a prospective cohort of 1499 BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 148:397\u2013406","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"9827_CR25","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-09-0171","volume":"18","author":"DG Evans","year":"2009","unstructured":"Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A (2009) Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomark Prev 18(8):2318\u20132324","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"9827_CR26","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2013.12.014","volume":"132","author":"C Garcia","year":"2014","unstructured":"Garcia C, Wendt J, Lyon L, Jones J, Littell RD, Armstrong MA, Raine-Bennett T, Powell CB (2014) Risk management options elected by women after testing positive for a BRCA mutation. Gynecol Oncol 132(2):428\u2013433","journal-title":"Gynecol Oncol"},{"issue":"4","key":"9827_CR27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10689-013-9625-z","volume":"12","author":"D Kim","year":"2013","unstructured":"Kim D, Kang E, Hwang E, Sun Y, Hwang Y, Yom CK, Kim K, No JH, Kim YB, Kim SW (2013) Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation. Fam Cancer 12(4):621\u2013628","journal-title":"Fam Cancer"},{"issue":"3","key":"9827_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.2006.07.4922","volume":"25","author":"JB Madalinska","year":"2007","unstructured":"Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Lubsen-Brandsma L, Massuger LF, Mourits MJ, Gaarenstroom KN, van Dorst EB, van der Putten H, Boonstra H, Aaronson NK (2007) Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1\/2 mutation carriers. J Clin Oncol 25(3):301\u2013307","journal-title":"J Clin Oncol"},{"issue":"5","key":"9827_CR29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","volume":"119","author":"R Manchanda","year":"2012","unstructured":"Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, Brunell C, Saridogan E, Gessler S, Oram D, Side L, Rosenthal AN, Jacobs I, Menon U (2012) Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis. BJOG 119(5):527\u2013536","journal-title":"BJOG"},{"issue":"1","key":"9827_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10689-012-9585-8","volume":"12","author":"B Meiser","year":"2013","unstructured":"Meiser B, Price MA, Butow PN, Karatas J, Wilson J, Heiniger L, Baylock B, Charles M, McLachlan SA, Phillips KA (2013) Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer. Fam Cancer 12(1):101\u2013109","journal-title":"Fam Cancer"},{"key":"9827_CR31","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00404-010-1476-3","volume":"283","author":"K Rhiem","year":"2011","unstructured":"Rhiem K, Foth D, Wappenschmidt B, Gevensleben H, Buttner R, Ulrich U, Schmutzler RK (2011) Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers. Arch Gynecol Obstet 283:623\u2013627","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"9827_CR32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bjc.2011.573","volume":"106","author":"L Sidon","year":"2012","unstructured":"Sidon L, Ingham S, Clancy T, Clayton R, Clarke A, Jones EA, Lalloo F, Evans DG (2012) Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women. Br J Cancer 106(4):775\u2013779","journal-title":"Br J Cancer"},{"key":"9827_CR33","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.ajog.2013.01.026","volume":"208","author":"K Singh","year":"2013","unstructured":"Singh K, Lester J, Karlan B et al (2013) Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Am J Obstet Gynecol 208:329.e1\u2013329.e6","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"9827_CR34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-0004.2009.01329.x","volume":"77","author":"AB Skytte","year":"2010","unstructured":"Skytte AB, Gerdes AM, Andersen MK, Sunde L, Br\u00f8ndum-Nielsen K, Waldstr\u00f8m M, K\u00f8lvraa S, Cr\u00fcger D (2010) Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing. Clin Genet 77(4):342\u2013349","journal-title":"Clin Genet"},{"key":"9827_CR35","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","volume":"23","author":"JB Madalinska","year":"2005","unstructured":"Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK (2005) Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynaecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 23:6890\u20136898","journal-title":"J Clin Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-015-9827-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-015-9827-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-015-9827-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T02:55:41Z","timestamp":1567047341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-015-9827-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9827"],"URL":"https:\/\/doi.org\/10.1007\/s10689-015-9827-7","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,12]]}}}